Bioinformatics / Healthcare
Adaptation of deep learning to biotechnology/life science industry
PFN conducts R&D and drive commercialization of deep learning application for omics analysis, medical image analysis, and drug discovery.
- omics analysis: early cancer detection using miRNA
- medical image analysis: disease identification using X-ray, CT and MRI images
- Drug discovery: structure-based screening of potential compounds
We continue to expand and accelerate our research efforts in the field of Biomedical and Life Sciences.
Biomolecules 2020 (selected for 2022 Best Paper Award)
Test-time adaptation for brain tumor segmentation with cross-institutional MRI
By : Junichiro Iwasawa
AI based Drug Design using Variational Autoencoder and Weighted Retraining
By : Ryuichiro Ishitani